Search

Fall 2017

Morrison, Hali A.E.K.

Ocular brachytherapy has been found to be an excellent alternative for the treatment of ocular melanomas compared to the predominantly used treatment prior to the 1980s of enucleation. Tumour control rates are generally >90%, overall survival rates are equivalent to enucleation, and ocular...

Spring 2017

Cawston-Grant, Brie C

Standard treatment planning in brachytherapy (BT) uses the well-accepted TG-43 dose calculation formalism, which does not account for tissue or material heterogeneities. However, recent developments in BT have led to commercial treatment planning systems (TPSs) using model based dose calculation...

Fall 2011

Ren, Jiyun

Currently, the Cross Cancer Institute uses CT imaging in conjunction with the traditional Manchester system, which prescribes dose to a defined point, for cervix cancer brachytherapy. To take advantage of MRI for enhanced definition of soft tissue including the cancerous tissue itself, this...

Spring 2023

Ghosh, Shrimanti

In locally advanced cervical cancer (LACC), brachytherapy (BT) remains the gold standard for boosting to curative doses in radiotherapy. Progress towards balancing target and routine tissue dosimetry for better clinical outcomes has been made possible by magnetic resonance imaging (MRI)-guided...

Spring 2022

Chow, Braden K

Cervical cancer is the fourth most common cancer worldwide, with an estimated 604,000 cases identified in 2020. The standard care for locally advanced cervical cancers is concurrent chemotherapy and external beam radiotherapy (EBRT) with a brachytherapy (BT) boost. Current guidelines recommend...